2 completed. 1 Not applicable, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Phosphoserine: new trials by email Literature Review of Phosphoserine trials Research Report on Phosphoserine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Coenzyme Q10 Plus NADH Supplementation in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Coenzyme Q10 plus NADH, phosphoserine plus vitamin C - Chronic Fatigue Syndrome | Not applicable | Completed | Hospital Universitari Vall d'Hebron Research Institute | 282 | 2017-06-28 | 2022-09-21 |
| Clinical Trial to Measure the Maximun HR After ReConnect ® Supplementation vs. Placebo in CFS. ReConnect (NADH plus CoQ10), placebo - Chronic Fatigue Syndrome | Phase 2 / Phase 3 | Completed | Hospital Universitari Vall d'Hebron Research Institute | 80 | 2013-01-01 | 2015-02-19 |
Fatigue Syndrome, Chronic (2) · Fatigue (1) · Pain (1) · Parasomnias (1) · Primary Dysautonomias (1)
Hospital Universitari Vall d'Hebron Research Institute (2)
Spain (2)
Jose Alegre, MD; PhD (1) · Jose Alegre-Martin, MD, PhD (1)
PMID 25386668, PMID 26212172, PMID 20447621, PMID 23514202, PMID 23600892, PMID 28052319